Info

🌱 來自: Febrile Neutropenia

Indications for granulocyte colony-stimulating factor

(G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF)

• often administered prophylactically after chemotherapy regimens associated with high incidence of neutropenic fever (see Table 1. Risk of Febrile Neutropenia, According to the Type of Cancer and Chemotherapy Regimen)
• may be given prophylactically after low- or intermediate-risk chemotherapy regimens in older patients or patients with high-risk comorbidities
• may be given to patients who do not receive prophylaxis but do not recover granulocyte counts to facilitate adherence to planned chemotherapy schedule in curative situations
• may be given to patients with neutropenic fever with high risk for infection-associated complications or factors predictive of poor outcome